Endocrinology News

The AMA House of Delegates adopted two new policies aiming to reform prior authorization and the burden it causes patients and physicians.

The U.S. Preventive Services Task Force has issued a draft recommendation stating that all women aged 65 years and older be screened for osteoporosis to prevent fractures.

PHILADELPHIA — In patients with acute MI who had successful PCI and underwent imaging to assess plaque composition, diabetes raised risk for poor outcomes but the difference was not related to plaque, according to a presentation.

PHILADELPHIA — Early, cost-effective screening may predict and prevent incident heart failure events for patients with diabetes and no prior heart disease, a speaker reported.

BOSTON — Long-term osilodrostat therapy may improve symptoms of comorbid cardiometabolic disorders such as hypertension and diabetes for adults with Cushing’s disease, according to data presented at ENDO 2024.

PHILADELPHIA — Despite there being few options to directly lower lipoprotein(a) as of yet, measurement is none the less important to identify those who would benefit from improved risk factor control, a speaker reported.

Most high and moderate risk factors for preeclampsia have increased from 2010 to 2021 in the U.S., according to a research letter published in JAMA.

PHILADELPHIA — In this Healio video exclusive, Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, highlights the need for greater prevention of myocardial infarction and cardiovascular death in young women.

The FDA granted clearance for two new over-the-counter continuous glucose monitoring systems, one for adults with type 2 diabetes who do not use insulin and another for adults without diabetes, according to an industry press release.

PHILADELPHIA — A task force has issued an updated multispeciality guide to help clinicians manage diabetes, cardiorenal and metabolic diseases.